INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 133 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,902 | -21.6% | 4,889,500 | -10.1% | 0.00% | 0.0% |
Q2 2023 | $2,427 | +12.1% | 5,436,281 | +105.9% | 0.00% | 0.0% |
Q1 2023 | $2,165 | -46.1% | 2,640,300 | +2.6% | 0.00% | -40.0% |
Q4 2022 | $4,013 | -99.9% | 2,572,500 | +10.7% | 0.01% | -16.7% |
Q3 2022 | $4,008,000 | +46.9% | 2,323,700 | +47.3% | 0.01% | +100.0% |
Q2 2022 | $2,729,000 | +93.0% | 1,577,500 | +300.5% | 0.00% | +50.0% |
Q1 2022 | $1,414,000 | -68.5% | 393,881 | -34.7% | 0.00% | -50.0% |
Q1 2020 | $4,487,000 | +278.3% | 603,123 | +67.8% | 0.00% | +300.0% |
Q4 2019 | $1,186,000 | +328.2% | 359,500 | +166.5% | 0.00% | – |
Q3 2019 | $277,000 | -56.1% | 134,900 | -37.2% | 0.00% | -100.0% |
Q2 2019 | $631,000 | -70.0% | 214,681 | -62.0% | 0.00% | -50.0% |
Q1 2019 | $2,105,000 | +57.0% | 564,281 | +68.3% | 0.00% | +100.0% |
Q4 2018 | $1,341,000 | -35.7% | 335,281 | -10.7% | 0.00% | -50.0% |
Q3 2018 | $2,087,000 | -27.3% | 375,381 | -43.2% | 0.00% | 0.0% |
Q2 2018 | $2,869,000 | +74.2% | 661,462 | +89.1% | 0.00% | 0.0% |
Q1 2018 | $1,647,000 | +9.6% | 349,781 | -3.9% | 0.00% | 0.0% |
Q4 2017 | $1,503,000 | -43.0% | 363,981 | -7.3% | 0.00% | -66.7% |
Q4 2015 | $2,639,000 | – | 392,781 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
Beck Bode, LLC | 41,218 | $33,799 | 0.01% |